Werewolf Therapeutics, Inc. (HOWL)

NCM – Real Time Price. Currency in USD

0.37

-0.01 (-2.66%)

Market open: Aug 12, 2026, 11:01 AM EDT

0.38

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

20M

16M

Cost of goods sold

-2M

-3M

Gross Profit

-2M

71K

18M

14M

Operating expenses (excl. COGS)

-59M

-74M

-59M

-70M

Operating Income

-61M

-74M

-41M

-56M

Non-operating income, total

-145K

Pretax income

-61M

-71M

-37M

-54M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-61M

-71M

-37M

-54M

Discontinued operations

Net income

-61M

-71M

-37M

-54M

Dilution adjustment

-1M

Preferred dividends

Werewolf Therapeutics, Inc. (HOWL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Werewolf Therapeutics, Inc. (HOWL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Werewolf Therapeutics, Inc. (HOWL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Werewolf Therapeutics, Inc. (HOWL)

Income Statement (Annual)

Income Statement (Annual)